Tilray Inc (NASDAQ:TLRY - Get Free Report) shares rose 6.9% on Friday . The company traded as high as $2.17 and last traded at $2.16. Approximately 17,430,049 shares traded hands during mid-day trading, a decline of 44% from the average daily volume of 30,999,646 shares. The stock had previously closed at $2.02.
Wall Street Analysts Forecast Growth
TLRY has been the subject of a number of recent analyst reports. CIBC lowered their price target on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating for the company in a report on Wednesday, April 10th. Alliance Global Partners upped their price target on shares of Tilray from $2.25 to $2.75 and gave the company a "neutral" rating in a report on Friday, April 5th. Finally, Canaccord Genuity Group lowered their price target on shares of Tilray from $4.25 to $4.00 and set a "buy" rating for the company in a report on Wednesday, April 10th.
Get Our Latest Stock Analysis on Tilray
Tilray Trading Up 4.0 %
The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The firm has a market capitalization of $1.63 billion, a PE ratio of -4.77 and a beta of 2.36. The stock's 50-day simple moving average is $1.98 and its 200-day simple moving average is $1.94.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Clear Street Markets LLC bought a new position in Tilray in the 3rd quarter worth $25,000. Simplicity Wealth LLC bought a new position in shares of Tilray in the 1st quarter worth about $28,000. RPO LLC bought a new position in shares of Tilray in the 4th quarter worth about $28,000. Great Valley Advisor Group Inc. bought a new position in shares of Tilray in the 3rd quarter worth about $29,000. Finally, Gainplan LLC bought a new position in shares of Tilray in the 4th quarter worth about $28,000. 9.35% of the stock is currently owned by institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
